CureVac Shares Hit All-Time Low on German Patent Court Ruling
19 Décembre 2023 - 6:12PM
Dow Jones News
By Dean Seal
Shares of CureVac fell to an all-time low after the company said
a German federal court has denied the validity of an intellectual
property patent related to messenger ribonucleic acid technology in
Covid-19 vaccines.
The stock dropped 41% to a low of $3.41 on Tuesday. Shares have
fallen by a third since the start of the year.
The German biopharmaceutical company said the German Federal
Patent Court granted a nullity action filed against CureVac's
patent by rival BioNTech.
The two competitors are in ongoing patent litigation involving
eight CureVac intellectual property rights. Proceedings regarding
the seven remaining rights will be decided individually.
CureVac said it will appeal the German court's decision.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
December 19, 2023 11:57 ET (16:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
CureVac NV (NASDAQ:CVAC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
CureVac NV (NASDAQ:CVAC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
